United Therapeutics (UTHR) Current Deferred Tax Assets (2009 - 2013)

United Therapeutics has disclosed Current Deferred Tax Assets across 5 years of filings, most recently posting $14.6 million for Q2 2013.

• Current Deferred Tax Assets for Q2 2013 came in at $14.6 million, up 77.51% year-over-year; the trailing twelve-month figure through Jun 2013 was $14.6 million (up 77.51% YoY), and the FY2012 annual result was $14.6 million, up 77.51% from the prior year.
• Current Deferred Tax Assets came in at $14.6 million for Q2 2013 at United Therapeutics, roughly flat from $14.6 million in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $14.6 million in Q4 2012 to a low of $2.3 million in Q1 2011.
• The 5-year median for Current Deferred Tax Assets is $8.2 million (2011), against an average of $9.0 million.
• Across the five-year window, Current Deferred Tax Assets sank 80.39% in 2011 and surged 255.09% in 2012, its largest moves.
• United Therapeutics' Current Deferred Tax Assets stood at $7.2 million in 2009, then soared by 74.99% to $12.6 million in 2010, then tumbled by 34.85% to $8.2 million in 2011, then soared by 77.51% to $14.6 million in 2012, then changed by 0.0% to $14.6 million in 2013.
• The last three Current Deferred Tax Assets figures came in at $14.6 million (Q2 2013), $14.6 million (Q1 2013), and $14.6 million (Q4 2012), per Business Quant data.